A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

Clinical trial NCT07030712 · RECRUITING

Trial details

NCT number: NCT07030712
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Neoplasm

Start date: 2025-07-23
Primary completion: 2029-07-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.